Bayer, Syngenta end patent dispute

2002-01-11 15:33

Leverkusen - German chemicals and pharmaceuticals giant Bayer said on Friday it had settled its dispute with Swiss agrochemicals group Syngenta over the intellectual property rights for neonicotinoids, a new type of chemical used in insecticides.

Bayer had sued Syngenta because it believed thiamethoxam, the active ingredient used in many of the Swiss group's insecticides, infringed on its US, European and Japanese patents for the active ingredient Indimacloprid used in many of its own insecticides.

Bayer claimed its Indimacloprid patents covered the chemical make-up of thiamethoxam.

But Syngenta rejected that, insisting that thiamethoxam did not infringe on Bayer's patents in any way.

In order to put an end to the costly lawsuits and countersuits in the US, Europe and Japan, both sides had reached an agreement whereby Syngenta would pay US$120 million to Bayer.

In return, both Bayer and Syngenta would retain full access for their respective products for crop protection and related markets worldwide. -Sapa-AFP